Amgen settles with AbbVie over Humira biosimilar
Thousand Oaks biopharmaceutical giant Amgen announced Sept. 28 that it had reached a settlement with Chicago-based competitor AbbVie, which had sued to block Amgen’s Humira biosimilar Amjevita. The rheumatoid arthritis and inflammation treatment received U.S. Food and Drug Administration approval in September of 2016, but sales were blocked when AbbVie filed a patent infringement claim Read More →
Amgen agrees to develop biosimilars for Chinese market
Increasing its global footprint in the biosimilars market, Amgen announced Sept. 26 that it had formed an exclusive co-development agreement with Chinese drug manufacturer Simcere Pharmaceutical Group. The agreement aims to bring four oncology and inflammation biosimilars in Amgen’s portfolio to commercialization in China. The Thousand Oaks-based biotechnology company will produce and submit approval applications Read More →
Cal Poly SLO gets $500,000 grant to fund startup development
The Cal Poly San Luis Obispo Center for Innovation and Entrepreneurship received $500,000 to fund startup development in the county as part of an effort to mitigate job losses from the proposed closure of the Diablo Canyon nuclear power plant. U.S. Rep. Salud Carbajal, D-Santa Barbara, announced on Sept. 18 that the Department of Commerce’s Read More →
California’s labor shortage can be fixed
By Jordan Cunningham California has a huge hole in our skilled labor force. Construction companies scramble to find carpenters, electricians, iron workers and those in other specialized careers that make up the construction workforce. Nearly 70 percent of California contractors said they’re having difficulty filling positions for installation specialists. Roughly 50 percent said it’s difficult Read More →

Input sought on plan to close Diablo Canyon nuclear power plant by 2025
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.







